Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.
Huang L, Garrett Injac S, Cui K, Braun F, Lin Q, Du Y, Zhang H, Kogiso M, Lindsay H, Zhao S, Baxter P, Adekunle A, Man TK, Zhao H, Li XN, Lau CC, Wong STC.
Huang L, et al.
Sci Transl Med. 2018 Oct 24;10(464):eaat0150. doi: 10.1126/scitranslmed.aat0150.
Sci Transl Med. 2018.
PMID: 30355798
Free PMC article.